HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes.

Abstract
Curcumin, a polyphenolic compound derived from turmeric, has protective effects on myocardial injury through attenuation of oxidative stress and inflammation. Toll-like receptor 2 (TLR2), a key mediator of the innate immune system, is involved in myocardial infarction and examined if controlled by curcumin. Rat cardiomyocytes (CMs) were stimulated with tumor necrosis factor (TNF)-α, peptidoglycan (PGN) or hypoxia/reoxygenation (H/R) with or without curcumin pretreatment. Sprague-Dawley rats were fed curcumin (300 mg/kg/day) 1 week before cardiac ischemia/reperfusion (I/R) injury. The expression level of TLR2 and cardiac function were assessed. Both mRNA and protein of TLR2 were up-regulated in infarcted myocardium, while TLR4 remained unchanged. In CMs, TLR2 and monocyte chemoattractant protein (MCP)-1 mRNAs were increased by TNF-α, PGN or H/R, whereas they were blunted by curcumin. Immunofluorescence staining of CMs also showed that TLR2 and MCP-1 were increased after H/R, whereas curcumin-pretreated CMs were not. In animal study, 2 weeks after I/R, TLR2 was increased in the infarct zone, whereas it stayed unchanged in the Cur+I/R group. Macrophage infiltration (CD68), high-mobility group box 1 and fibrosis were increased in the I/R group, whereas they were decreased in the Cur+I/R group. Connexin 43 was reduced in the I/R group, while it recovered significantly in the Cur+I/R group. Cardiac contractility in the Cur+I/R group was also improved compared with that in the I/R group (max dp/dt in Cur+I/R group: 9660±612 vs. I/R group: 8119±366, P<.05). These results suggest that selective inhibition of TLR2 by curcumin could be preventive and therapeutic for myocardial infarction.
AuthorsYong Sook Kim, Jin Sook Kwon, Young Kuk Cho, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang, Youngkeun Ahn
JournalThe Journal of nutritional biochemistry (J Nutr Biochem) Vol. 23 Issue 11 Pg. 1514-23 (Nov 2012) ISSN: 1873-4847 [Electronic] United States
PMID22402367 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Cardiotonic Agents
  • Ccl2 protein, rat
  • Chemokine CCL2
  • HMGB1 Protein
  • Hbp1 protein, rat
  • Peptidoglycan
  • Tlr2 protein, rat
  • Tlr4 protein, rat
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • Curcumin
Topics
  • Animals
  • Cardiotonic Agents (pharmacology)
  • Chemokine CCL2 (genetics, metabolism)
  • Curcumin (pharmacology)
  • HMGB1 Protein (genetics, metabolism)
  • Male
  • Myocardial Infarction (drug therapy, metabolism, pathology)
  • Myocardial Reperfusion Injury (prevention & control)
  • Myocytes, Cardiac (drug effects, metabolism)
  • Peptidoglycan (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Toll-Like Receptor 2 (genetics, metabolism)
  • Toll-Like Receptor 4 (genetics, metabolism)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: